Jeongho Oak joined PRISM BioLab in 2025 to lead Translational Pharmacology. He brings extensive experience from a postdoctoral fellowship in cardiology at the University of Chicago and from Takeda Pharmaceutical, where he advanced drug discovery projects in cardiovascular and metabolic diseases. At Takeda, he also led nonclinical safety assessment initiatives within the Drug Safety Research Evaluation. He earned his Ph.D. from Tohoku University.